The Government of Canada has made substantial investments-more than $13 billion since 1997-that have built a strong foundation in basic science and technology, including the Canada Foundation for Innovation, health research and other initiatives to create leading-edge capabilities. It will continue to build on this strength.
Speech from the Throne, October 5, 2004
Recognizing the progress that has been made, the federal government commits to continued investments to sustain activities in support of health innovation.
FMM, September 16, 2004
The health accord puts everybody's focus where it should be-on shortening waiting times, getting more health care professionals and better equipment, improving primary care, home care and drug coverage, better services in the North and for Aboriginal people, more health research and innovation, and improved public health and wellness.
Minister Ralph Goodale, 2004 fall Economic and Fiscal Update
E. coli
Cattle vaccine developed that prevents E. coli from entering the food supply now being marketed worldwide by a Canadian biotech company. (Dr. Brett Finlay, UBC)
ALS
Antibiotic commonly prescribed for acne may slow the development of ALS, providing hope for thousands of Canadians. (Dr. Jean-Pierre Julien, McGill)
Cardiac Care
Study finds that vast majority of heart attacks may be predicted by nine easily measurable factors, providing evidence needed to build national and international prevention and control programs. (Dr. Salim Yusuf, McMaster)
HIV/AIDS
First Canadian-led trial of a therapeutic HIV vaccine underway. Promising vaccine combines drug products in an effort to boost the immune systems of HIV sufferers. (Dr. Jonathan Angel, University of Ottawa)
| Burden of Illness Ranking | Burden of Illness ($)* | CIHR Funding ($ in 03/04)** | |
|---|---|---|---|
| Cardiovascular diseases | 1 | 18.5B | 109M |
| Musculoskeletal | 2 | 16.4B | 42M |
| Cancer | 3 | 14.2B | 94M |
| Injuries | 4 | 12.7B | 21M |
| Respiratory diseases | 5 | 8.5B | 38M |
* Economic Burden of Illness in Canada, 1998 (Table 2), Page 7
** For Funded Projects that Received a CIHR Financial Commitment in Fiscal Year 2003-2004
Mental Illness

Dr. Patricia Martens and the "Need to Know Team", University of Manitoba
Cardiac Care

Dr. Jack Tu, Institute of Clinical Evaluative Sciences
Patient Safety
Pacemakers
Single chamber pacemakers are as effective as dual chamber
CIHR investment $2.2 M / Annual health care savings $10M
Dialysis
Providing dialysis at night is less stressful for patients and less costly
CIHR investment $180K / Annual health care savings $43M
Ear Surgery
Specialized procedure prevents the need for surgery on children with ear problems
CIHR investment $342K / Annual health care savings $300M
Croup
Treating all 75,000 Canadian children who get croup each year immediately with steroids reduces follow-up physician visits by half
CIHR investment $223K / Annual health care savings $1.5M

Through CIHR's Proof of Principle program, Dr. Mandar Jog, London Health Sciences Centre, is working with a Canadian biotech company to commercialize his innovate Parkinson's-related technology.
CIHR launched its strategic plan (Blueprint) in January 2004 to usher in the next step in its evolution. The five key areas where CIHR will focus from 2003-2008 are:
Clinical Research Initiative (with CFI)
Bridging the gap between what we know and what we do
Modernizing Canada's platform for clinical research
Regenerative Medicine (with NSERC, NRC, Heart and Stroke Foundation, others)
Harnessing the new sciences of nanotechnology, stem cells and biomaterials
Creating multidisciplinary research teams to study the rapidly expanding field of regenerative medicine and nanomedicine
Global Health Research Initiative (with IDRC, CIDA and Health Canada)
Affirming Canada's place in the world
Developing practical solutions for the health problems of the developing world
Recommendation:
The Government increase CIHR's annual base budget from $662M to $1 Billion over three years and provide flexibility for carry over of 5% of funds.